Optimizing Early & Late Stage
Asset Planning and Drug Development

What We Do

We provide strategic consulting to pharmaceuticals companies, biotech and VC firms on multiple touchpoints during asset planning and drug development journey

Ophthalmology

Front and back of the eye disease indications

Cell & Gene Therapy

AAV/CRISPR-based cell and gene therapy indications

Neuroscience

Broad array of neurological diseases and disorders 

Rare/Orphan Diseases

Genetic and orphan diseases across multiple TAs

About Us

Our capabilities and know-how include early and late stage asset planning & development, asset validation, due diligence, business development, corporate and commercial strategy support on various therapeutic areas of focus

“We help accelerate your pipeline assets” 

+ YR EXPERIENCE
0
+ THERAPEUTIC AREAS
0
+ DISEASE FOCUS AREAS
0
% SCIENCE-DRIVEN
0
We bring 360° in-depth scientific experience and expertise in preclinical and clinical drug development in ophthalmology and other disease focus areas
Ophthalmology
Anterior and posterior segment diseases
Neuroscience
Neurodegenerative diseases and disorders
Gene Therapy
Inherited diseases and other indications
Orphan Diseases
Rare diseases and disorders in multiple TAs

Where We Help

We provide strategic and technical consulting solutions covering drug development aspect from R&D discovery, preclinical & clinical planning and development, market and asset data analytics, corporate strategy, BD and M&A support on multiple therapeutics and disease focus areas
Preclinical & Clinical Development
We provide preclinical and clinical development support on drug candidates & target assets
Corporate & Commercial Support
We provide corporate, BD and commercial strategy support on internal & external assets

Contact Us

Address

4445 Eastgate Mall, San Diego, CA 92121

Phone

(+1) 858-GO1-8307

Email

Message us